Thryv Therapeutics is a genetic disorder that causes a prolongation between the beginning of the QRS complex and the end of the T waveQ and T waves on the EKG, indicating a prolongation of ventricular repolarization and the action potential duration. The lengthening of this complex is associated with unexpected and life-threatening ventriculararrhythmias. Click below to learn more about our programs.

Biotechnology

Therapeutics

Thryv Therapeutics

Paul F. Truex

Philip Sager

Aidan McNeil

Debra Odink

Shi Yin Foo

Frédéric Lemaître Auger

Michael J Ackerman

Daniel Hétu

Arthur A.m. Wilde

Stanley Nattel

Robert Booth

Saumya Das

Melissa Koomey

Dinesh Srinivasan

Marc-Olivier Sirard

Anthony Rosenzweig

Scott Weiner

Jean-François Pariseau

The Research and Development team at Thryv Therapeutics is dedicated to advancing innovative treatments for genetic disorders related to ventricular repolarization and arrhythmias. This team conducts cutting-edge research, develops new drug candidates, and oversees clinical trials to ensure the safety and efficacy of therapies. Through collaboration among scientists, clinicians, and regulatory experts, they aim to translate complex biological data into actionable therapies that improve patient outcomes.

Research and Development

The Corporate Governance team at Thryv Therapeutics is responsible for overseeing the company's governance framework, ensuring compliance with regulatory requirements, and providing strategic guidance to the executive team and board of directors. This team plays a crucial role in promoting transparency, accountability, and ethical conduct within the organization, while also supporting decision-making processes that align with the company's mission to address genetic disorders.

Corporate Governance

The Leadership Team at Thryv Therapeutics is responsible for guiding the company's strategic direction and overseeing the development of innovative treatments for genetic disorders. They focus on advancing research initiatives, ensuring compliance with regulatory standards, and fostering collaboration across departments to drive the successful translation of scientific discoveries into viable therapies. Their collective expertise helps to navigate the complex landscape of drug development while prioritizing patient safety and therapeutic efficacy.

Leadership Team

Thryv Therapeutics

Org chart

Board & advisors

Teams

Research and Development

Corporate Governance

Leadership Team

Offices

Thryv Therapeutics

Org chart

Board & advisors

Teams

Research and Development

Corporate Governance

Leadership Team

Offices

Related companies